Raymond James analyst Rahul Sarugaser is feeling confident in Ginkgo Bioworks Holdings (Ginkgo Bioworks Stock Quote, Chart, News NYSE:DNA), maintaining his “Outperform 2” rating and target price of $11.50/share for a projected return of 385.2 per cent in an update to clients on Tuesday. Boston-based Ginkgo Bioworks builds bespoke living cells through the use of […]
Liminal Biosciences’ price target cut at Leede Jones GableDouglas Loe of Leede Jones Gable is not loving what he’s seeing from Liminal Biosciences (Liminal Biosciences Stock Quote, Charts, News, Analysts, Financials NASDAQ:LMNL), maintaining a “Hold” rating and dropping his target price from $2.50/share to $2/share (all figures in this article are in US dollars) with any return listed as not available in an […]